Latest news
Neurizon advances ALS trial in Q4 FY26 - The AustralianThe Australian · Tue, 04 Aug 2026 03:12:00 GMTNeurizon Completes 250-Participant HEALEY ALS Trial Enrolment and Secures $17.5M R&D Financing Facility - KalkineKalkine · Fri, 31 Jul 2026 07:00:00 GMTNeurizon Therapeutics Completes Regimen I Enrolment in HEALEY ALS Platform Trial Ahead of Melbourne Investor Briefing - KalkineKalkine · Wed, 29 Jul 2026 04:02:01 GMT